Cancer cell resistance mechanisms: A mini review

Clinical and Translational Oncology

Volumn 16, Issue 6, 2014, Pages 511-516

  Al Dimassi, S ^a   Abou Antoun, T ^a   El Sibai, M ^a  

^a LEBANESE AMERICAN UNIVERSITY   (Lebanon)

Author keywords

Cancer; Chemotherapy resistance; Immunotherapy resistance and cancer stem cells; Multiple drug resistance; Radiotherapy resistance

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; IMMUNOMODULATING AGENT; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 1; PROTEIN P53; SCATTER FACTOR RECEPTOR; SURVIVIN;

ABC TRANSPORTER GENE; ANGIOGENESIS; APOPTOSIS; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CELL CONTACT; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNE RESPONSE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANCE GENE 1; NONHUMAN; ONCOGENE; ONCOGENE MET; SHORT SURVEY; TUMOR ESCAPE; TUMOR INVASION; TUMOR SUPPRESSOR GENE; ANIMAL; DRUG RESISTANCE; NEOPLASMS; RADIATION DOSE;

ANIMALS; DRUG RESISTANCE, NEOPLASM; HUMANS; NEOPLASMS; RADIATION TOLERANCE;

EID: 84901600999     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-014-1162-1     Document Type: Short Survey

References (43)

1. Garcia M, Jemal A. Global cancer facts and figures. Atlanta: American Cancer Society; 2007.
2. Baskar R, Lee KA, Yeo R, Yeoh K-W. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193-9. doi:10.7150/ijms.3635.
3. American Cancer Society. Cancer facts and figures 2013. Atlanta: American Cancer Society; 2013. p 2013.
4. Dalkic E, Wang X, Wright N, Chan C. Cancer-drug associations: a complex system. PLoS One. 2010;5(4):e10031. doi:10.1371/journal.pone.0010031.
5. Hanahan D, Weinberg R. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646-74. doi:10.1016/j.cell.2011.02.013.
6. Bhosle J, Hall G. Principles of cancer treatment by chemotherapy. Surgery (Oxford). 2009;27(4):173-7.
7. Borst P, Elferink R. Mammalian ABC transporters in health and disease. Annu Rev Biochem. 2002;71:537-92. doi:10.1146/annurev.biochem.71.102301.093055. (Pubitemid 34800230)
8. Dean M, Hamon Y, Chimini G. The human ATP-binding cassette (ABC) transporter superfamily. J of Lipid Res. 2001;11(7):1156-66. (Pubitemid 32677289)
9. Lubelski J, Konings W, Driessen A. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Micro Mol Bio Rev. 2007;71(3):463-76. doi:10.1128/MMBR.00001-07. (Pubitemid 47429281)
10. Chen J, Lu G, Davidson A, Qutocho F. A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Moll Cell. 2003;12(3):651-61. (Pubitemid 37222486)
11. Sarkadi B, Homolya L, Szakacs G, Varadi A. Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev. 2006;86(4):1179-236. doi:10.1152/physrev.00037.2005. (Pubitemid 44521651)
12. Huff L, J-S LEE, Robey R, Fojo T. Characterization of gene rearrangements leading to activation of MDR-1. J Biol Chem. 2006;281(48):365019. doi:10.1074/jbc.M602998200.
13. Stavrovskaya A, Stromskaya T. Transport proteins of the ABC family and multidrug resistance of tumor cells. Biochemistry. 2008;73(5):592-604. doi:10.1134/S0006297908050118. (Pubitemid 351775081)
14. Davidson A, Elie D, Orelle C, Chen J. Structure, function, and evolution of bacterial ATP-binding cassette systems. Microbiol mol bio rev. 2008;72(2):317-64. doi:10.1128/MMBR.00031-07.
15. Hipfner D, Deeley R, Cole S. Structural, mechanistic and clinical aspects of MRP1. Biochim Biophys Acta. 1999;1461(2):359-76. doi:10.1016/S0005-2736(99) 00168-6.
16. Schwab M, Eichelbaum M, Fromm M. Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol. 2003;43:285-307. doi:10.1146/annurev.pharmtox.43.100901.140233. (Pubitemid 37372643)
17. González-Pons M, Szeto A, González-Méndez R, Serrano A. Identification and bioinformatic characterization of a multidrug resistance associated protein (ABCC) gene in Plasmodium berghei. Malar J. 2009;8:1. doi:10.1186/1475-2875-8-1.
18. Leslie E, Deeley R, Cole S. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharm. 2005;204(3):216-37. doi:10.1016/j.taap.2004.10.012. (Pubitemid 40552845)
19. Yin J-Y, Huang Q, Yang Y, Zhang J-T, Zhong M-Z, Zhou H-H, et al. Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population. Pharmacogenet Genomics. 2009;19(3):206-16. doi:10.1097/FPC.0b013e328323f680.
20. Kyle-Cezar F, Echevarria-Lima J, Goldenberg R, Rumjanek V. Expression of c-kit and Sca-1 and their relationship with multidrug resistance protein 1 in mouse bone marrow mononuclear cells. Immunology. 2007;121(1):122-8. doi:10.1111/j.1365-2567.2007.02547.x. (Pubitemid 46537671)
21. Akan I, Akan S, Akca H, Savas B, Ozben T. Multidrug resistance-associated protein 1 (MRP1) mediated vincristine resistance: effects of N-acetylcysteine and Buthionine sulfoximine. Cancer Cell Int. 2005;5:22. doi:10.1186/1475-2867-5- 22.
22. Kasinathan R, Morgan W, Greenberg R. Schistosoma mansoni express higher levels of multidrug resistance-associated protein 1 (SmMRP1) in juvenile worms and in response to praziquantel. Mol Biochem Parasitol. 2010;173(1):25-31. doi:10.1016/j.molbiopara.2010.05.003.
23. Mao Q, Unadkat J. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS Journal. 2005;7(1):E118-33. doi:10.1208/aapsj070112. (Pubitemid 41554295)
24. Marchan R, Hammond C, Ballatori N. Multidrug resistance-associated protein 1 as a major mediator of basal and apoptotic glutathione release. Biochim Biophys Acta. 2008;1778(10):2413-20. doi:10.1016/j.bbamem.2008.06.011.
25. Mao Q, Unadkat J. Role of the breast cancer resistance protein (ABCG2) in drug transport. AAPS J. 2005;7(1):E118-33. doi:10.1208/aapsj070112. (Pubitemid 41554295)
26. Zhu M, Tong J, Xu Q, Nie F, Xu X, Xiao S, et al. Increased JNK1 signaling pathway is responsible for ABCG2-mediated multidrug resistance in human colon cancer. PLoS One. 2012;7(8):e41763. doi:10.1371/journal.pone.0041763.
27. Li X, Pan Y-Z, Seigel G, Hu Z-H, Huang M, Yu A-M. Breast cancer resistance protein BCRP/ABCG2 regulatory microRNAs (hsa-miR-328, -519c and -520 h) and their differential expression in stem-like ABCG2+ cancer cells. Biochem Pharmacol. 2011;81(6):783-92. doi:10.1016/j.bcp.2010.12.018.
28. Mo W, Zhang J-T. Human ABCG2: structure, function, and its role in multidrug resistance. Int J Biochem Mol Biol. 2012;3(1):1-27.
29. Begg A, Stewart F, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer. 2011;11:239-53. doi:10.1038/nrc3007.
30. Ghisolfi L, Keates A, Hu X, Lee D-k, Li C. Ionizing radiation induces stemness in cancer cells. PLoS One. 2012;7(8):e43628. doi:10.1371/journal.pone. 0043628.
31. Suit H. Local control and patient survival. Int J of Rad Oncol Bio Phys. 1992;23(3):653-60. doi:10.1016/0360-3016(92)90025-D.
32. Barcellos-Hoff M, Park C, Wright E. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer. 2005;5:867-75. doi:10.1038/nrc1735. (Pubitemid 41746031)
33. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer. 2003;3(3):155-68. doi:10.1038/nrc1011. (Pubitemid 37328868)
34. Trusolino L, Comoglio P. Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer. 2002;2(4):289-300. doi:10.1038/nrc779. (Pubitemid 37328782)
35. De Bacco F, Luraghi P, Medico E, Reato G, Girolami F, Perera T, et al. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst. 2011;103(8):645-661. doi:10.1093/jnci/djr093.
36. Inanami O, Takahashi K, Kuwabara M. Attenuation of caspase-3-dependent apoptosis by Trolox post-treatment of X-irradiated MOLT-4 cells. Int J of Rad Bio. 1999;75(2):155-63. doi:10.1080/095530099140609. (Pubitemid 29089154)
37. Ambrosini G, Adida C, Altieri D. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3:917-21. doi:10.1038/nm0897- 917. (Pubitemid 27353455)
38. Asanuma K, Moriai R, Yajima T, Yagihashi A, Yamada M, Kobayashi D, et al. Survivin as a radioresistance factor in pancreatic cancer. Jpn J Cancer Res. 2000;91(11):1204-9. doi:10.1111/j.1349-7006.2000.tb00906.x.
39. Dillman R, Fogel GB, Cornforth AN, Selvan SR, Schiltz PM, DePriest C. Features associated with survival in metastatic melanoma patients treated with patient-specific dendritic cell vaccines. Cancer Biother Radiopharm. 2011;26(4):407-15. doi:10.1089/cbr.2011.0973.
40. Dunn G, Old L, Schreiber R. The immunobiology of cancer immunosurveillance and immunoediting. Immunity. 2004;21(2):137-48. doi:10.1016/j.immuni.2004.07.017. (Pubitemid 39094044)
41. Schreiber R, Old L, Smyth M. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science. 2011;331:1565-70. doi:10.1126/science.1203486.
42. Marincola F, Jaffee E, Hicklin D, Ferrone S. Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immuno. 2000;74:181-273. doi:10.1016/S0065-2776(08)60911-6.
43. Ribas A, Butterfield L, Glaspy J, Economou J. Current developments in cancer vaccines and cellular immunotherapy. J of Clin Oncol. 2003;21(12):2415-32. doi:10.1200/JCO.2003.06.041. (Pubitemid 46621880)